Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat (ZK 245186) in Atopic Dermatitis
NCT00944632Phase 2Completed
- Sponsor
- Bayer
- Start
- Jul 2009
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mapracorat in atopic dermatitis (AD), sponsored by Bayer. Started Jul 2009; status: completed.
02
Drugs
mapracorat
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00944632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944632.